Inflammation Causes Resistance to Anti-CD20-Mediated B Cell Depletion

One-year Results of the Effects of Rituximab on Acute Antibody-Mediated Rejection in Renal Transplantation

(2016) Bénédicte Sautenet et al.   TRANSPLANTATION

Rituximab as Induction Therapy After Renal Transplantation: A Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety

(2015) M. W. F. van den Hoogen et al.   AMERICAN JOURNAL OF TRANSPLANTATION

TIM-1 Signaling Is Required for Maintenance and Induction of Regulatory B Cells

(2015) M. Y. Yeung et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Anti-huCD20 Antibody Therapy for Antibody-Mediated Rejection of Renal Allografts in a Mouse Model

(2015) T. Abe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Antibody Effector Functions Mediated by Fcγ-Receptors Are Compromised during Persistent Viral Infection

(2015) Andreas Wieland et al.   IMMUNITY

B cells mediate chronic allograft rejection independently of antibody production

(2014) Qiang Zeng et al.   JOURNAL OF CLINICAL INVESTIGATION

Suppression of Proteoglycan-Induced Arthritis by Anti-CD20 B Cell Depletion Therapy Is Mediated by Reduction in Autoantibodies and CD4+ T Cell Reactivity

(2014) K. Hamel et al.   JOURNAL OF IMMUNOLOGY

A Single Dose of Rituximab Does Not Deplete B Cells in Secondary Lymphoid Organs but Alters Phenotype and Function

(2013) E. G. Kamburova et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Lessons for the clinic from rituximab pharmacokinetics and pharmacodynamics

(2013) Josée Golay et al.   mAbs

Properties of mouse and human IgG receptors and their contribution to disease models

(2012) P. Bruhns   BLOOD

A Randomized, Double-Blind, Placebo-Controlled Study of Single Dose Rituximab as Induction in Renal Transplantation

(2012) Gunnar Tydén et al.   TRANSPLANTATION

Regulatory B cells are identified by expression of TIM-1 and can be induced through TIM-1 ligation to promote tolerance in mice

(2011) Qing Ding et al.   JOURNAL OF CLINICAL INVESTIGATION

B Lymphocytes Differentially Influence Acute and Chronic Allograft Rejection in Mice

(2011) D. J. DiLillo et al.   JOURNAL OF IMMUNOLOGY

Mechanism of Action of Type II, Glycoengineered, Anti-CD20 Monoclonal Antibody GA101 in B-Chronic Lymphocytic Leukemia Whole Blood Assays in Comparison with Rituximab and Alemtuzumab

(2011) L. Bologna et al.   JOURNAL OF IMMUNOLOGY

An Acquired Defect in IgG-Dependent Phagocytosis Explains the Impairment in Antibody-Mediated Cellular Depletion in Lupus

(2011) A. Ahuja et al.   JOURNAL OF IMMUNOLOGY

Neonatal Fc receptor and IgG-based therapeutics

(2011) Timothy T. Kuo et al.   mAbs

Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus

(2010) Kai W. Bekar et al.   ARTHRITIS AND RHEUMATISM

Reduced-dose rituximab in rheumatoid arthritis: Efficacy depends on degree of B cell depletion

(2010) Edward M. Vital et al.   ARTHRITIS AND RHEUMATISM

Recipient B Cells Are Not Required for Graft-Versus-Host Disease Induction

(2010) Catherine Matte-Martone et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

(2010) S. A. Beers et al.   BLOOD

Preemptive CD20+ B cell depletion attenuates cardiac allograft vasculopathy in cyclosporine-treated monkeys

(2010) Shahrooz S. Kelishadi et al.   JOURNAL OF CLINICAL INVESTIGATION

CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis

(2010) S. Rosengren et al.   RHEUMATOLOGY

Comparison of Combination Plasmapheresis/IVIg/Anti-CD20 Versus High-Dose IVIg in the Treatment of Antibody-Mediated Rejection

(2009) C. Lefaucheur et al.   AMERICAN JOURNAL OF TRANSPLANTATION

M2 Macrophages Phagocytose Rituximab-Opsonized Leukemic Targets More Efficiently than M1 Cells In Vitro

(2009) M. Leidi et al.   JOURNAL OF IMMUNOLOGY

B-Cell–Depleting Induction Therapy and Acute Cellular Rejection

(2009) Menna R. Clatworthy et al.   NEW ENGLAND JOURNAL OF MEDICINE

B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy

(2009) Olivier Thaunat et al.   TRANSPLANTATION

BAFF May Modulate the Rate of B-Cell Repopulation After Rituximab Therapy for Acute Renal Transplant Rejection

(2009) Valeriya Zarkhin et al.   TRANSPLANTATION

Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus

(2008) D Albert et al.   ANNALS OF THE RHEUMATIC DISEASES

Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

(2008) Shouvik Dass et al.   ARTHRITIS AND RHEUMATISM

Rituximab and Intravenous Immune Globulin for Desensitization during Renal Transplantation

(2008) Ashley A. Vo et al.   NEW ENGLAND JOURNAL OF MEDICINE